Table 3

Age distribution of the most prevalent incidental findings

Finding45–54 years95% CI55–64 years95% CI65–75 years95% CI
(n=211)(n=245)(n=119)
White matter hyperintensities, n (%)*7 (3.32)(1.64 to 6.68)21 (8.57)(5.68 to 12.75)17 (14.29)(9.13 to 21.71)
Vascular abnormalities*
 Lacunar infarct, n (%)*2 (0.95)(0.29 to 3.36)6 (2.45)(1.15 to 5.23)8 (6.72)(3.48 to 12.71)
 Microhaemorrhage, n (%)*05 (2.04)(0.90 to 4.67)4 (3.36)(1.36 to 8.31)
 Single cavernous malformation, n (%)2 (0.95)(0.29 to 3.36)8 (3.26)(1.6 to 6.30)4 (3.36)(1.36 to 8.31)
 Malformation of venous development, n (%)9 (4.26)(2.28 to 7.90)10 (4.08)(2.25 to 7.37)1 (0.84)(0.20 to 4.55)
Neoplasias
 Meningioma, n (%)3 (1.42)(0.51 to 4.07)5 (2.04)(0.90 to 4.67)2 (1.68)(0.52 to 5.89)
 Pituitary mass, n (%)02 (0.82)(0.25 to 2.90)0
 Small intraventricular mass,† n (%)1 (0.47)(0.11 to 2.60)00
 Cerebellar hemispheric mass, n (%)01 (0.41)(0.09 to 2.24)0
Brain volume loss*
 Frontal, n (%)*01 (0.41)(0.90 to 2.24)7 (5.88)(2.92 to 11.64)
 Temporal, n (%)*2 (0.95)(0.29 to 3.36)2 (0.82)(0.25 to 2.90)4 (3.36)(1.36 to 8.31)
 Parietal, n (%)*2 (0.95)(0.29 to 3.36)2 (0.82)(0.25 to 2.90)4 (3.36)(1.36 to 8.31)
 Cerebellum and brain stem, n (%)1 (0.47)(0.11 to 2.60)1 (0.41)(0.90 to 2.24)2 (1.68)(0.52 to 5.89)
 Diffuse loss of brain volume, n (%)*1 (0.47)(0.11 to 2.60)4 (1.63)(0.66 to 4.11)8 (6.72)(3.48 to 12.71)
  • *Statistically significant positive correlation with increasing age (r, p<0.005).

  • †Possible subependymoma.